Enhancing hepatic fatty acid oxidation as a strategy for reversing metabolic disorders programmed by maternal undernutrition during gestation

Cell Physiol Biochem. 2014;33(5):1498-515. doi: 10.1159/000358714. Epub 2014 May 14.

Abstract

Background/aims: Moderate maternal calorie-restriction during gestation programmes offspring for a major propensity to develop metabolic alterations in adulthood. We aimed to assess whether increased hepatic fatty-acid oxidation (FAO), at early ages, by gene transfer of Cpt1am (active mutant of carnitine palmitoyltransferase-1a), may be a strategy for reversing metabolic disturbances associated to maternal calorie-restriction during gestation in rats.

Methods: AAV-Gfp (control) and AAV-Cpt1am vectors were administered by tail vein injection in 18-day-old control-pups and the offspring of 20% calorie-restricted rats during gestation (CR). After weaning, animals were fed with normal-fat diet. At the age of 4 months, they were moved to HF-diet and sacrificed at the age of 6 months to collect tissues. Locomotive activity, energy expenditure and blood pressure were measured.

Results: Under HF-diet, CR-animals showed higher HOMA-IR, adipocyte diameter and hepatic triglyceride accumulation than controls; these alterations were reverted in Cpt1am-injected animals. In liver, this treatment ameliorated inflammatory state, decreased expression of lipogenesis-related genes and partially restored the decreased expression of leptin-receptor occurring in CR-animals. Treatment also reverted the decreased energy expenditure and the increased blood pressure of CR-animals.

Conclusion: Increasing hepatic FAO through AAV-Cpt1am injection at juvenile ages prevents some metabolic disorders associated to gestational maternal calorie-restriction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carnitine O-Palmitoyltransferase / genetics
  • Carnitine O-Palmitoyltransferase / metabolism
  • Fatty Acids / metabolism*
  • Fatty Liver / metabolism*
  • Female
  • Genetic Therapy*
  • Humans
  • Male
  • Malnutrition / metabolism*
  • Metabolic Diseases / etiology
  • Metabolic Diseases / genetics
  • Metabolic Diseases / metabolism*
  • Metabolic Diseases / therapy*
  • Oxidation-Reduction
  • Pregnancy
  • Pregnancy Complications / metabolism*
  • Pregnancy, Animal
  • Prenatal Exposure Delayed Effects / genetics
  • Prenatal Exposure Delayed Effects / therapy*
  • Rats
  • Rats, Wistar

Substances

  • Fatty Acids
  • Carnitine O-Palmitoyltransferase